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L-type calcium channels (LTCCs), also known as CaV1 family, are subject
to diverse perturbations while acting as signaling hubs in cells, including
autonomous modulations by the distal carboxyl terminus (DCT) of its own.
Previous studies show that DCT of CaV1.3 and CaV1.4 (i.e., DCTD and
DCTF respectively) competes with calmodulin (CaM) for IQ and IQ vicinity
(IQ-IQV) of the channel, which results in attenuation of calcium dependent
inactivation (CDI) (Liu et al. 2010). In parallel, DCTC (i.e., DCT of
CaV1.2) could autonomously inhibit voltage-gated activation (VGA) of
the channel (Hulme et al. 2006). Here, our data demonstrate that distal
carboxyl-terminus regulatory domain (DCRD) across CaV1 family could
mediate both inhibition of CDI (I-CDI) and inhibition of VGA (I-VGA), sug-
gesting a unified scheme of competitive autoregulation by DCRD across
CaV1 family. Thus, the apparent discrepancy in phenotypes of I-CDI and/
or I-VGA among CaV1 subtypes can be largely attributed to the different
configurations of DCT/IQ-IQV complex. Under such scheme, in addition to
well-documented I-VGA, the proteolyzed carboxyl-terminus (CCT) of
LTCC in neurons could also induce I-CDI. Both I-VGA and I-CDI play
crucial roles in CaV1 signaling in neurons. Our results here provide
converged mechanisms across CaV1 channel subtypes in their DCT modula-
tions, highlighting the importance of comparative studies in the context of
whole-family of CaV1 channels. Moreover, this study also reveals innovative
features from CaV1.1 and CaV1.2, inviting further investigations into mecha-
nism and physiology of DCTs.
2932-Pos Board B362
Modal Bifurcation of Cav1.3 Signaling in Cortical Neurons
Min Liu1,2, Yaxiong Yang1, Nan Liu1, Ji Tang1, Xuyang Sun1,
Xiaodong Liu1,3.
1School of Medicine, Tsinghua Univ, Beijing, China, 2Tsinghua-Peking
Center for Life Sciences, Beijing, China, 3School of Life Sciences, Beijing,
China.
L-type Ca2þ channels, emerging as one of the central signaling hubs in
healthy and diseased neurons, play prominent roles in diverse essential pro-
cesses. However, it still remains largely as a puzzle how the same channel
could simultaneously fulfill opposed tasks of signaling in neurons. Here we
report that CaV1.3 channels are bifurcated into subpopulations with two
distinct modes of signaling: n-mode signaling and p-mode signaling. This
modal bifurcation is first demonstrated by genetically-encoded Ca2þ channel
tuners (GECTs) of iCaMp and eCaMp, bioengineered to perturb autonomous
competition between calmodulin and distal carboxyl tail of CaV1.3 channel.
Channels driven into p-mode by eCaMp tend to produce ‘‘sharp and large’’
Ca2þ influx, which is kinetically distinguished from ‘‘blunt and small’’
Ca2þ influx via n-mode channels by iCaMp. Moreover, in cultured cortical
neurons, modal bifurcation of CaV1.3 channels provides a pair of homeostatic
opponents leading to constructive and destructive signaling events, eventually
to morphological changes. In these neurons, kinase and phosphatase are pref-
erentially activated by respective p-mode or n-mode channels and signals.
Correspondingly, CaV1.3 signaling complex switches between its configura-
tions to facilitate such signaling preference. Finally, the capabilities of
GECTs, especially those of eCaMp in promoting p-mode channels and sig-
nals, highlight a new strategy to modulate L-type Ca2þ channels, as potential
therapeutics for disorders with certain malfunctioned channels and/or dys-
regulated homeostasis.
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The electrophysiological properties of voltage-gated calcium channel
(VGCC) complexes are determined by the specific combination of subunit
isoforms, i. e. of one pore-forming CaVa1 subunit and the auxiliary subunits
b, a2-d (and g). Therefore, VGCCs differentially modulate the cellular
response to stimuli, which is relevant for neuronal function. Interestingly,
the CaVa1C and CaVb2-subunit genes have been shown to be risk loci for
five major psychiatric disorders including autism spectrum disease (ASD)(Lancet (2013) 381:1371). Our group has recently found three missense
mutations in the CaVb2 gene in ASD patients; while two mutants (G167S,
S197F) resulted in a retardation of inactivation behavior, one mutant
(F240L) accelerated the inactivation of whole-cell Ba2þ currents (PLOS
One (2014) 9(4): e95579). In the present study, we performed single channel
patch clamp of HEK cells co-transfected with CaVb2 mutants and CaVa1C.
The gating parameters revealed a pronounced biophysical phenotype for all
mutations: G167S and S197F persisted longer in an open state by elongating
its mean open time (p ¼ 0.005). F240L showed a trend for an increased open
probability. Further, the transition rate constants obtained from Markov
modelling of the single-channel data were consistent with the observed
gating parameters. Here, the Markov model revealed significantly deceler-
ated transition from open to closed state for G167S (p ¼ 0.008) and
S197F (p ¼ 0.03). Both G167S and S197F showed slower transition rates
suggesting a preference for deeper closed states (for S197F p ¼ 0.04).
That would explain why their open probabilities are not increased while
mean open times are elongated. We conclude that the three mutations,
each exhibiting different biophysical mechanisms, lead to the same outcome:
more channel activity.
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Recent reports identified six calmodulin (CaM) missense mutations associated
with three distinct human arrhythmia syndromes: N54I and N98S are associ-
ated with catecholaminergic polymorphic ventricular tachycardia (CPVT)-
like clinical presentations, D96V, D130G and F142L with long QT syndrome
(LQTS) and F90L with idiopathic ventricular fibrillation (IVF). We previously
reported that all LQTS-CaMs exhibit reduced Ca affinity and normal or
decreased (compared to WT CaM) ryanodine receptor (RyR2)-binding
affinity, whereas CPVT-CaMs have normal or modestly lower Ca affinity
but increase RyR2 single-channel open probability and show enhanced
binding affinity to RyR2, causing significant increase in spontaneous
Ca wave and spark activity in cardiac myocytes. Here, we investigate the
effect of these mutant CaMs on another target potentially involved in
arrhythmogenesis - Cav1.2 channels.
Using whole-cell patch clamp, Cav1.2 current (ICa) was measured in freshly
isolated murine ventricular myocytes pre-treated with ryanodine (50 mM) and
thapsigargin (10 mM) to prevent SR Ca release. Cells were dialyzed with either
wild-type or mutant CaM (6 mM) via patch pipette. All LQTS-CaMs and IVF-
CaM caused significant impairment of ICa inactivation: t¼254534 ms
(D96V), 251510 ms (F142L), 187513 ms (D130G) and 19058 ms (F90L)
vs. 11055 ms for WT (p<0.001, n¼4-7 myocytes/group), whereas CPVT-
CaMs had no effect on ICa inactivation(t¼10853 ms (N54I), t¼132514
ms (N98S) (NS, n¼4-6 myocytes/group)). The effect of LQTS-CaMs and
IVF-CaM was dominant, with a mixture of 25% mutant/75%WT CaM slowing
ICa inactivation to a similar degree as 100%mutant CaM. Importantly, average
peak current amplitude was unchanged in all groups. These results support the
hypothesis that different targets are affected in arrhythmogenic disorders asso-
ciated with LQTS-CaMs (impaired regulation of Cav1.2) vs. CPVT-CaMs
(altered regulation of RyR2). The F90L CaM mutation shares characteristics
with both CPVT and LQTS CaMs.
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Epilepsy affects 1 in 140 people, or nearly 50 million people worldwide. It is
characterized by seizures that often result from neuronal hyper-excitability.
A recent genome-wide study uncovered many mutations associated with epi-
lepsy in voltage-gated calcium channels (VGCC). However, the molecular
and cellular consequences of these mutations, and hence, their epileptogenic
mechanisms remain unknown. Here, we investigated two mutations that
occur in PQ-type voltage-gated calcium channels, which are responsible for
neurotransmitter release: R477H (in the I-II loop) and Q1957X (a truncation
mutation). The mutations were introduced into a human PQ channel in
the pGEMHE vector. The DNA for WT or mutant channels, together with
the DNA for other VGCC subunits required for proper channel expression,
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quently injected into Xenopus oocytes, and channel currents were examined us-
ing Two-Electrode Voltage Clamp four days later. We thus compared the
biophysical properties of WT and mutant channels. We found that the
R477H mutation shifts the voltage dependence of inactivation to more depolar-
ized voltages, rendering the mutant channels more difficult to inactivate
compared to the WT channel. In addition, the time constant of inactivation
was slower for the mutant. At the same time, the voltage dependence of activa-
tion was unchanged. These results suggest a potential mechanism for epilepto-
genesis: reduced channel inactivation would contribute to increased cellular
excitability and excitotoxicity - two hallmarks of epilepsy. The results also
highlight the role of the I-II loop of VGCC in channel inactivation. As for
the Q1957X mutation, our current hypothesis is that this mutant generates no
currents. In addition, we hypothesize that the Q1957X mutant will act as a
dominant negative regulator of coexpressed WT channels via the unfolded pro-
tein response.
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The human L-type calcium channel (CaV1.2) is a multi-protein complex
consisting of the pore-forming a1c subunit and at least two auxiliary subunits,
b and a2d, which assemble in a 1:1:1 stoichiometry. b subunits regulate mul-
tiple aspects of CaV1.2 channel physiology, including surface expression,
degradation and gating. Investigating the effect of b2a and b3 subunits on
human CaV1.2 channels (a1cþa2d) expressed in Xenopus oocytes, we found
that the voltage dependences of total charge displacement (QV) and conduc-
tance (GV) were ~10mV more negative in the presence of b2a. We tested
the hypothesis that b2a and b3 subunits differently modulate the activation
of the four voltage-sensor domains (VSDs) in the a1c subunit. Using the
Voltage-Clamp Fluorometry technique, we fluorescently tracked the move-
ment of individual VSD in conducting human CaV1.2 channels. We found
that, in the presence of b2a, the voltage-dependent activation of VSDs II
and III was left-shifted as compared to b3-associated CaV1.2 (VSD II
with b2a: Vhalf¼ 31.151.0 mV, z¼ 4.550.8 e0; VSD II with b3: Vhalf¼
26.551.8 mV, z¼ 2.450.1 e0; VSD III with b2a: Vhalf¼ 36.653.9 mV,
z¼ 1.850.1 e0; VSD III with b3: Vhalf¼ 16.951.4 mV, z¼ 1.250.1 e0).
Moreover, activation and deactivation kinetics of VSD II in channels asso-
ciated with b2a were dramatically slower than in the presence of b3, while
voltage- and time-dependent properties of VSD IV remained the same in
the presence of either Cavb subunit. These results suggest that, in spite of
their highly-conserved sequence homology, different b subunit isoforms
distinctly modulate the biophysical properties of CaV1.2 voltage sensors to
mediate their effect on Ca conductance.2937-Pos Board B367
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The a2d-1 auxiliary subunit binds to the pore-forming a1c subunit of voltage-
gated L-type calcium channels (CaV1.2) and facilitates both membrane
trafficking and voltage-dependent activation. Using voltage-clamp fluorometry
to study human CaV1.2 channels expressed in Xenopus oocytes, we have
recently found that a2d-1 association, in the presence of b3 subunits, causes
voltage sensor domains (VSDs) I, II and III, but not IV, to activate at more hy-
perpolarized potentials (DVhalf¼ 39mV, 32mV, 18mV for VSDs I-III
respectively) and with steeper voltage-dependence (z fold increase with a2d-
1: 1.9, 2.2 and 1.6 for VSDs I-III respectively). Thus, the a2d-1-induced
facilitation of CaV1.2 voltage-dependent activation seems to be mediated
through the remodeling of three VSDs.
We analyzed our voltage-clamp fluorometry data with a 32-state allosteric
model for CaV1.2 activation, consisting of five gating particles (one pore,
four VSDs). By simultaneously fitting kinetic and steady-state data fromthe pore (ionic currents) and from the individual VSDs (fluorescence), we
estimated the energetic contribution of each VSD to pore opening in the
presence and in the absence of a2d-1. The model predicts that, in channels
not associated with a2d-1, all VSDs were poorly energetically-coupled to
pore opening. The association of a2d-1 with a1cþb3 specifically increased
the coupling energy of VSDs II and III to the pore. In agreement with the model
prediction, we found that without a2d-1 subunits the ionic current deactivation
is largely voltage-independent.
A low-resolution structure of CaV1.2 channel complexes shows that the a2d-1
subunit forms a cap that embraces ~3=4 of the extracellular surface of the a1c
subunit (Walsh et al., JBC 2009). Based on our results, we propose that the
exposed ¼ of the a1c subunit is VSD IV, which does not show evidence of
functional interaction with a2d-1 subunits.2938-Pos Board B368
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Pain signaling is initiated by the detection of noxious stimuli through
specialized primary nociceptors located in peripheral endings in dorsal
root ganglion (DRG) neurons. Low voltage activated CaV3.2 T-type calcium
channels play a major role in sensory perception in these neurons; silencing
their activity with antisense RNA or genetic ablation results in anti-
nociceptive, anti-hyperalgesic and anti-allodynic effects1-3. These channels
are regulated by a plethora of proteins, including KLHL1, a neuronal actin
binding protein that stabilizes channel activity by increasing its recycling
back to the plasma membrane via recycling endosome activity. We explored
the role of KLHL1 and its effects on CaV3.2 and mechanical peripheral pain
transmission using the KLHL1 KO mouse model. Total T-type calcium cur-
rent amplitude was smaller in KO DRG neurons (12 5 2.03 pA/pF, n¼18)
compared to controls (18 5 1.89 pA/pF, n¼13; p<0.05), without significant
changes in voltage dependence as expected in the absence of its modulator.
Western blot analysis confirmed CaV3.2 but not CaV3.1 or CaV3.3 protein
was significantly decreased. Interestingly, von Frey hair tests show paw
withdrawal threshold in KO mice was increased. Our data establishes
KLHL1 is a calcium channel regulator in DRG neurons, providing a novel
target to control peripheral pain sensation. Downregulation of CaV3.2 acti-
vity by as little as ~30% was sufficient to alter pain perception in the KO
model.2939-Pos Board B369
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Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disorder. It is
commonly associated with cardiomyopathy that is characterised by disrupted
cytoskeletal architecture and mitochondrial dysfunction. Activation of the
L-type Ca2þ channel (LTCC) provides the Ca2þ influx required for contraction,
but also causes an increase in mitochondrial membrane potential (Jm) in a
calcium-independent manner. This involves the movement of cytoskeletal
proteins and regulation of mitochondrial VDAC. The increase in Jm (JC-1
fluorescence) after activation of LTCC is absent in cardiomyocytes isolated
from hearts of mdx mice, a murine model of DMD (1.551.0%, n¼4 vs.
12.151.4%, n¼10 in C57BL/10ScSnArc controls) but can be restored
using antisense morpholino oligomers to induce exon skipping of dystrophin
exon 23 (M23D). Here we investigate the effects of M23D peptides on
changes in Jm and mitochondrial oxygen consumption (flavoprotein auto-
fluorescence) induced by LTCC activation. Male (M) and female (F) neonatal
mdx mice were injected (i.p.) for 3 weeks and divided into two treatment
groups: (i) 120mg/kg once per week; (ii) 30mg/kg four times per week.
Activation of LTCC with the dihydropyridine agonist BayK(-) induced an
increase in Jm in cardiomyocytes from animals treated with a single weekly
dose (M: 1752%, n¼5; F: 1653%, n¼12) and with multiple weekly doses
